According to filings with the U.S. Securities and Exchange Commission, Pelvital USA dba Flyte is raising $4,561,668.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Lydia Zeller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Pelvital USA dba Flyte
Founded in 2016, Pelvital is a privately held medical technology company focused on womens health. Our vision is to significantly improve the lives of people who suffer from pelvic floor disorders through novel, easy-to-use products backed by strong clinical evidence. We are focused on expanding conservative treatment options to inspire consumers to treat conditions rather than cope with symptoms. Our first product, Flyte, is a simple, effective in-home treatment for stress urinary incontinence, designed to treat weakened pelvic floor muscles to reduce bladder leaks and restore continence.

To learn more about Pelvital USA dba Flyte, visit http://flytetherapy.com/

Contact:
Lydia Zeller, Chief Executive Officer
866-735-8482

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.